New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
18:00 EDTBONEBacterin reports preliminary Q2 revenue $8.75M-$8.85M, consensus $8.93M
The company sees preliminary Q2 operating loss ($1.5M)-($1.4M). The company sees preliminary Q2 EBITDA of ($800K)-($900K). Gross margin for Q2 is expected to be 61%-63%.
News For BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 6, 2015
07:33 EDTBONEBacterin announces OsteoSponge patent
Bacterin International Holdings announced that the United States Patent and Trademark Office has issued US Patent No. 8,992,964 entitled "Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors." The issued claims in the patent cover certain demineralized bone matrixes containing minimum levels of bone morphogenetic protein-2, which include products in Bacterin's OsteoSponge product line. Bacterin has pending continuing applications in the United States to pursue protection on other aspects of its bone demineralization technology.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use